Navigation Links
Rheumatoid in Medical News

TNF Blockers May Help Some With Rheumatoid Arthritis

If standard treatment fails, more intensive therapy works well, study finds THURSDAY, Aug. 6 (HealthDay News) -- Patients with early rheumatoid arthritis (RA) who respond poorly to standard treatment with methotrexate may benefit from additional treatment with tumor necrosis factor (TN...

Decision Resources' Updated Rheumatoid Arthritis Report Now Includes Forecast for Rigel Pharmaceuticals' Fostamatinib Disodium

WALTHAM, Mass., Aug. 6 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, today released its updated Pharmacor Rheumatoid Arthritis report which now includes patient share and sales forecasts through 2018...

Lexicon Initiates Phase 2 Clinical Trial of LX2931 in Patients With Rheumatoid Arthritis

THE WOODLANDS, Texas, Aug. 4 /PRNewswire-FirstCall/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX ), a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease, announced today that it has initiated a Phase 2 cli...

Rigel to Host Conference Call to Discuss Results of Its Phase 2b TASKi3 Clinical Trial of R788 in Rheumatoid Arthritis

SOUTH SAN FRANCISCO, Calif., July 23 /PRNewswire-FirstCall/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL ) today announced that the Company plans to host a conference call on Thursday, July 23, 2009 at 7:00 pm EDT (4:00 pm PDT). Members of Rigel's senior management team and the p...

For Treatment of Rheumatoid Arthritis, Surveyed Rheumatologists and Patients Differ In Their Perception of Bristol-Myers Squibb's Orencia

WALTHAM, Mass., July 22 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that surveyed rheumatologists' perception of Bristol-Myers Squibb's Orencia is low among rheumatoid arthrit...

Brazil's Rheumatoid Arthritis Drug Market Will Grow $115 Million by 2013

WALTHAM, Mass., July 20 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that the rheumatoid arthritis drug market in Brazil will grow from $200 million in 2008 to more than $315 m...

More>>

Rheumatoid in Medical Technology

Rigel's R788 Significantly Improves Rheumatoid Arthritis in Phase 2b Clinical Trial

SOUTH SAN FRANCISCO, Calif., July 9 /PRNewswire-FirstCall/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL ) today announced that R788 (fostamatinib disodium) produced significant clinical improvement in rheumatoid arthritis (RA) patients in the recently completed TASKi2 Phase 2b clinical trial of ...

Rigel to Host Conference Call to Discuss Results of Its Phase 2b TASKi2 Clinical Trial of R788 in Rheumatoid Arthritis

SOUTH SAN FRANCISCO, Calif., July 8 /PRNewswire-FirstCall/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL ) today announced that the Company plans to host a conference call on Thursday, July 9, 2009 at 8:00 am EDT (5:00 am PDT). Members of Rigel's senior management team and the principal investig...

Thiarabine Demonstrates a Reduction of Both Inflammatory and Erosive Disease Parameters in Rheumatoid Arthritis

DALLAS, July 7 /PRNewswire-FirstCall/ -- ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP) announced today new preclinical data demonstrating that thiarabine shows remarkable efficacy in the prevention and treatment of rheumatoid arthritis (RA). In a well-established animal model...

SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis

Positive Opinion Recommends Approval of New Anti-TNF Therapy in Three Rheumatic Diseases with Novel SmartJect(TM) Autoinjector HORSHAM, Pa. and KENILWORTH, N.J., June 26 /PRNewswire-FirstCall/ -- Centocor Ortho Biotech Inc. and Schering-Plough Corporation (NYSE: SGP ) announced today that t...

Proteolix, Inc. Drug Candidate, PR-957, Prevents Disease Progression in Rheumatoid Arthritis Models by Selective Inhibition of the Immunoproteasome

Findings Published in Nature Medicine Suggest Broad Implications for the Treatment of Inflammatory and Autoimmune Disorders SOUTH SAN FRANCISCO, Calif., June 15 /PRNewswire/ -- Proteolix, Inc. announced that in an article published today in Nature Medicine, Proteolix's selective immunoprote...

New Analysis Shows Efficacy of SIMPONI(TM) (golimumab) in Anti-TNF Experienced Rheumatoid Arthritis Patients

Anti-TNF Experienced Patients Demonstrated Improvement With Every-Four-Week Subcutaneous SIMPONI Despite Previous Medication or Reason for Discontinuation COPENHAGEN, June 9 /PRNewswire/ -- A new analysis demonstrated that a greater proportion of patients with moderately to severely active rh...

More>>

Rheumatoid in Medical Products

Rheumaton Rheumatoid Factor Test

Description: Hemagglutination slide test for the qualitative and quantitative detection of Rheumatoid Factor in serum or synovial fluid....
Company:Inverness Medical Innovations

Rheumatex Rheumatoid Factor Test

Description: Latex agglutination slide test for the qualitative and quantitative determination of Rheumatoid Factor in serum....
Company:Inverness Medical Innovations

Colorcard RF Rheumatoid Factor Test

Description: A Color-Enhanced Slide Agglutination Test for the Rapid Qualitative and Semi-Quantitative Detection of Rheumatoid Factor in Serum....
Company:Inverness Medical Innovations

ImmuLisa Rheumatoid Factor IgG (RF) Kit

Description: An enzyme linked immunosorbent assay (ELISA) for the detection and quantitationof RF IgG isotype in human serum of patients with rheumatoid arthritis....
Company:IMMCO Diagnostics

ImmuLisa™ Rheumatoid Factor Screen Kit

Description: Rheumatoid factor screening...
Company:IMMCO Diagnostics

ImmuLisa™ Rheumatoid Factor IgM (RF) Kit

Description: An enzyme linked immunosorbant assay (ELISA) for the detection and quantitation of Rheumatoid Factor (RF) of IgM isotype in human serum....
Company:IMMCO Diagnostics

More>>

Rheumatoid in Medical Dictionary

Rheumatoid

Rheumatoid arthritis (RA) is a chronic, systemic inflammatory disorder that may affect many tissues and organs, but principally attacks the joints producing a inflammatory synovitis that often progresses to destruction of the... Treatment of rheumatoid arthritis ... How is rheumatoid...

Vasculitis

...d severity. ... Vasculitis is a condition in which blood vessels become inflamed. ... Both small and medium sized arteries can be involved in rheumatoid vasculitis . ... Vasculitis — Comprehensive overview covers symptoms, causes, treatment of this inflammation of the blood vess...

Uveitis

..... Uveitis is swelling and irritation of the uvea, the middle layer of the eye. ... Uveitis can be caused by autoimmune disorders such as rheumatoid arthritis or ... Provides information for doctors and patients about uveitis and other eye inflammations, and cataract, corneal, and refrac...

Uric acid

... Video of Uric Acid / Tophi Deposits caused by Gout Attacks in Dissected Big Toe. ... Sometimes uric acid problems are even misdiagnosed as rheumatoid Arthritis. ... ...

Tolmetin

...kanoic acids. It is used primarily to reduce hormones that cause pain, swelling, tenderness, and stiffness in conditions such as osteoarthritis and rheumatoid arthritis, including juvenile rheumatoid... Drug information on prescription and over the counter medications includes drug interactions, use...

Tendon

... ... ... foot and ankle fracture, ankle sprain, tendon tear, nerve pain, heel pain and plantar fascitis ... Peroneal Tendon Dysfunction. rheumatoid Arthritis ... Achilles tendon rupture — Comprehensive overview covers symptoms, causes, treatment ... toes on the injured leg, i...
Rheumatoid in Biological News

New trigger for chronic inflammation in rheumatoid arthritis discovered

A signal molecule made by the human body that triggers the immune system into action may be important in rheumatoid arthritis, according to new research published today in Nature Medicine . The authors of the study, from Imperial College London, say that if scientists could block this signal, it ...

Researchers identify new risk factor gene for rheumatoid arthritis

Scientists at The Feinstein Institute for Medical Research and a team of collaborators from across the country have identified a new risk factor gene for rheumatoid arthritis. The paper will be published in Nature Genetics and the finding brings light to the nature of the disease. The gene, dubb...

Gene therapy demonstrates benefit in patients with rheumatoid arthritis

BOSTON -- Researchers have reported the first clinical evidence that gene therapy reduces symptoms in patients with rheumatoid arthritis, an important milestone for this promising treatment which has endured a sometimes turbulent past. Described in the February issue of the journal Human Gene T...

Anakinra for rheumatoid arthritis: A modest benefit with some risk

New research supports a modest beneficial effect of anakinra for rheumatoid arthritis patients, but warns against potential risks for serious infections and its use with other biologic medications. Rheumatoid arthritis is a chronic inflammatory disease affecting as many as one in 100 people wor...

New therapeutic target identified for rheumatoid arthritis

Researchers at Hospital for Special Surgery have identified a potential new therapeutic target that could be used to treat inflammatory disorders, such as rheumatoid arthritis. The study, published online ahead of print, will appear Nov. 15 in the journal Immunity . Specifically, the study re...

New guidelines for treating rheumatoid arthritis

BIRMINGHAM, Ala. Proven combinations of medicines and the introduction of new anti-arthritis drugs have significantly improved the treatment of rheumatoid arthritis (RA), according to guidelines issued by the American College of Rheumatology and co-authored by physicians at the University of Alab...
Rheumatoid in Biological Technology

Video: New Way RA(TM) Talk Show Premieres Online for People Living With Rheumatoid Arthritis (RA)

HORSHAM, Pa., July 29 /PRNewswire/ -- New Way RA (TM), a new online talk show hosted by award-winning journalist and anchor of Inside Edition, Deborah Norville, premieres today at www.NewWayRA.com . To view the Multimedia News Release, go to: http://www.prnewswire.com/...

New Survey Reveals That More Than Half of Rheumatoid Arthritis Patients in Europe and Canada Feel Their Disease Controls Their Lives

Three-of-Four Patients Surveyed Experience Daily Pain From Rheumatoid Arthritis Despite Current Treatment; Findings Unveiled at the European League Against Rheumatism Annual Congress of Rheumatology COPENHAGEN, Denmark, June 10 /PRNewswire-FirstCall/ -- Results from the Rheumatoid Arthritis: ...

Health Canada Approves SIMPONI(TM) (golimumab) for Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis

Canadian Approval Is World's First Regulatory Approval for SIMPONI HORSHAM, Pa. and KENILWORTH, N.J., April 13 /PRNewswire-FirstCall/ Centocor Ortho Biotech Inc. and Schering-Plough Corporation (NYSE: SGP ) today announced that Health Canada has granted approval of SIMPONI (TM) (go...

Antiangiogenic Role of 2ME2 Demonstrated in Rheumatoid Arthritis Models

ROCKVILLE, Md., Nov. 3 /PRNewswire-FirstCall/ -- EntreMed, Inc. (Nasdaq: ENMD ), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, today announced the publication of preclinical results for 2ME2 (Panzem(R) or 2- methoxyestra...

Golimumab Phase 3 Data Show Significant Improvement In Physical Function In Patients with Rheumatoid Arthritis

Findings Also Showed Patients Experienced Improvements in Quality of Life Measures and Fatigue Despite Treatment with Other Anti-TNFs or Methotrexate SAN FRANCISCO, Oct. 27 /PRNewswire/ -- Results from two Phase 3 studies showed that patients receiving every four week subcutaneous injections of...

Trubion Reports Re-treatment Results Following Phase 1/2a and Phase 2b Studies Evaluating TRU-015 for Rheumatoid Arthritis

SEATTLE, Oct. 27 /PRNewswire-FirstCall/ -- Trubion Pharmaceuticals Inc. (Nasdaq: TRBN ) today announced positive data from a Phase 1/2a study demonstrating that repeat administration with TRU-015 continues to produce persistent responses and significant improvements in rheumatoid arthritis (R...
Rheumatoid in Biological Products

Anti-Rheumatoid Factor Monoclonal Antibody, Unconjugated from QED Bioscience Inc.

Description:...ndividuals. It does not cross-react with IgM, IgA, or IgG proteins lacking rheumatoid factor nor with pooled F(Ab)2 fragments. This antibody can be used in ELISA to detect rheumatoid factor. Product Category: Hormone and Serum Protein Antibodies...
Company:QED Bioscience Inc.
Rheumatoid in Biological Definition

Antibody

...; many can be detected through blood tests . "Designed" monoclonal antibody therapy is already being employed in a number of diseases (including rheumatoid arthritis ) and in some forms of cancer . Presently , many antibody-related therapies are undergoing extensive clinical trials for use in practice...

Immune system

...mune disorders such as lupus erythematosus , type I diabetes (sometimes called "juvenile onset diabetes"), multiple sclerosis , psoriasis , and rheumatoid arthritis . In these the immune system fails to properly distinguish between self and non-self and attacks a part of the patient's own body. Other exa...

Immunology

...ic granulomatous disease ), and autoimmunity , in which the immune system attacks its own antigens (examples include systemic lupus erythematosus , rheumatoid arthritis , Hashimoto's disease and myasthenia gravis ). Other immune system disorders include different hypersensitivities , in which the system ...
Rheumatoid in Biological Dictionary

Uric acid

... Video of Uric Acid / Tophi Deposits caused by Gout Attacks in Dissected Big Toe. ... Sometimes uric acid problems are even misdiagnosed as rheumatoid Arthritis. ... In human blood, uric acid concentrations between 3.6 and 8.3 mg/dL are ... The disease gout in humans is associated with eleva...

Monoclonal

... antibody, Rabbit antibody ... Monoclonal ... IgG Monoclonal . WB. Source: Mouse. Reactivity: Human - Not yet tested in ... ... treatments for rheumatoid arthritis are monoclonal antibodies. What is a monoclonal antibody? ... Monoclonal antibodies are laboratory produced ... ... murine monoc...

Biologics

...d and plasma products from the FDA. ... Recall of Medical Devices - Biomet Biologics , Inc ... Learn about biologics , a newer type of drug for rheumatoid arthritis treatment. ... Biologics may also cause some chronic diseases that are dormant (such as ... Manufactures the Omnicon and Samba image an...
Other Tags
(Date:11/23/2014)... 2014 Locks-Magnetic.com, a notable magnetic locks ... all the new products are available at low rates ... is proud of the new emergency doors. The emergency ... customers can choose from several colors. All of the ... emergency door release is not as easy as many ...
(Date:11/23/2014)... 23, 2014 More than two dozen ... a federal litigation involving Byetta lawsuits ( http://www.byettalawsuit2013.com/ ), ... Liebhard LLP reports. , A Case List updated ... class of Type 2 diabetes medications referred to as ... District Court, Southern District of California, where a federal ...
(Date:11/23/2014)... Church, VA (PRWEB) November 23, 2014 ... TV Have in Common, **FDAnews On-Demand Webinar**, Dec. 11, ... http://www.fdanews.com/TheFDAisWatchingOnDemand , The FDA’s focus on promotional activities ... , Now they're looking at websites, Twitter, ... Mark the calendar for Thursday, Dec. 11, for On-Demand ...
(Date:11/23/2014)... Salt Lake City, Utah (PRWEB) November 23, 2014 ... in individual health insurance reimbursement for small businesses, ... the new book, The End of Employer-Provided Health ... employer-provided health insurance is the greatest financial risk ... greatest challenge facing U.S. employers, small and large, ...
(Date:11/22/2014)... (PRWEB) November 23, 2014 PrettyTailor ... website with a new big promotion. Customers can buy ... detailed information, customers can visit its website. , As ... apparel and occasion dresses. It mainly provides four types ... bride dresses and flower girl dresses. It also provides ...
Breaking Medicine News(10 mins):Health News:California Federal Court Overseeing Byetta Lawsuits, Other Incretin Mimetic Claims Adds New Cases in November, Bernstein Liebhard LLP Reports 2Health News:California Federal Court Overseeing Byetta Lawsuits, Other Incretin Mimetic Claims Adds New Cases in November, Bernstein Liebhard LLP Reports 3Health News:California Federal Court Overseeing Byetta Lawsuits, Other Incretin Mimetic Claims Adds New Cases in November, Bernstein Liebhard LLP Reports 4Health News:FDAnews Announces The FDA is Watching: What Twitter, Tradeshows and TV Have in Common, On-Demand Webinar, Dec. 11, 2014 2Health News:FDAnews Announces The FDA is Watching: What Twitter, Tradeshows and TV Have in Common, On-Demand Webinar, Dec. 11, 2014 3Health News:FDAnews Announces The FDA is Watching: What Twitter, Tradeshows and TV Have in Common, On-Demand Webinar, Dec. 11, 2014 4Health News:FDAnews Announces The FDA is Watching: What Twitter, Tradeshows and TV Have in Common, On-Demand Webinar, Dec. 11, 2014 5Health News:Zane Benefits, Inc. Announces New Webinar on The End of Employer-Provided Health Insurance Now Available On-Demand! 2Health News:Customers Are Welcome to Shop at PrettyTailor.com 2
(Date:11/7/2014)... BURBANK, Calif. , Nov. 7, 2014  In conjunction ... Burbank Police Departments, The Community Foundation of the ... BURBANK DNA JUSTICE PROJECT," a $250,000 initiative to ... successful initial phase. In its first six months of existence, ... desperately needed evidence support for local law enforcement. ...
(Date:11/6/2014)... Insilico Medicine, Inc, a Baltimore-based bioinformatics company focused ... announced a research collaboration with the international leader ... (OTC: CSBR). , "There are many companies utilizing ... Oncology,s TumorGraft technology is unique in a way ... generating vast amounts of valuable data. Our bioinformatic ...
(Date:11/4/2014)... In nature, the right amount of death at the ... density, according to new research that could help in ... wildlife stocks. , In a paper in the journal ... University researcher and European colleagues conclude that the kind ... a loss of individuals, or mortality, depends on the ...
Breaking Biology News(10 mins):Community Foundation Of The Verdugos Unveils Campaign To Fund Glendale-Burbank DNA Justice Project 2Insilico Medicine, Inc announces research collaboration with Champions Oncology, Inc 2When less is more: Death in moderation boosts population density in nature 2
Other Contents